(19)
(11) EP 3 347 473 A1

(12)

(43) Date of publication:
18.07.2018 Bulletin 2018/29

(21) Application number: 16845141.7

(22) Date of filing: 09.09.2016
(51) International Patent Classification (IPC): 
C12N 15/39(2006.01)
 C12N 5/0783(2010.01)
(86) International application number:
PCT/US2016/050994
(87) International publication number:
WO 2017/044780 (16.03.2017 Gazette 2017/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 09.09.2015 US 201562216046 P
09.09.2015 US 201562216062 P
13.11.2015 US 201562255294 P
15.04.2016 US 201662323065 P

(71) Applicant: Tvax Biomedical I, LLC
Olathe, KS 66061 (US)

(72) Inventors:
  • WOOD, Gary
    Olathe, KS 66061 (US)
  • STRITZKER, Jochen Harald
    La Jolla, CA 92037 (US)

(74) Representative: Murgitroyd & Company 
Scotland House 165-169 Scotland Street
Glasgow G5 8PL
Glasgow G5 8PL (GB)

   


(54) METHODS FOR COMBINING ADOPTIVE T CELL THERAPY WITH ONCOLYTIC VIRUS ADJUNCT THERAPY